Humain Ventures
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://www.humain.vc
- HQ
- TX
Humain Ventures backs founders building the future of therapeutics, prevention, and human health. Its portfolio includes Radicle Science, which runs large, decentralized, placebo-controlled trials to give consumer wellness products real evidence; Profile Health, a clinical operating system that combines genome, records and clinical data into a plan a doctor can use; Trace Health, a passive toilet-mounted sensor that reads urine, starting with stress and recovery hormones; and Metabologic, which designs enzymes that work on food to improve how the body processes it.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Healthtech, Biotech | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Humain Ventures Fund I, LP Humain Ventures backs founders building therapeutics, prevention, and human health. It favors Tech Bio, where AI and programmable biology change how drugs are built, and prevention-first health systems. It also backs consumer-owned health data through wearables and continuous biosensing. Inferred from the firm's website | 2024 | $5.3M to $10M (Form D) | Open, writing first checks |
03 · People across funds
- Aneil Mallavarapu, Managing Partner of the Manager of the General Partner of the Fund
Humain Ventures Fund I, LP (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026